1. Methamphetamine exposure increases cardiac microvascular permeability by activating the VEGF-PI3K-Akt-eNOS signaling pathway, reversed by Bevacizumab
   Rui Chen et al, 2022, Human & Experimental Toxicology CrossRef
2. Efficacy of Intrapleural or Intrapericardial Injection of Single Bevacizumab in the Treatment of Lung Cancer-Mediated Malignant Effusion
   Dongyun He et al, 2022, Canadian Respiratory Journal CrossRef
3. Malignus pleuralis effusiókkal küzdő betegek ellátása egy regionális onkológiai központban a COVID–19-pandémia időszakában
   Emőke Papp et al, 2022, Orvosi Hetilap CrossRef
4. In Vitro and In Silico Studies on 4-Nitroacetophenone Thiosemicarbazone Potential Cytotoxicity Against A549 Cell Lines
   Neha Verma et al, 2023, Applied Biochemistry and Biotechnology CrossRef
5. Comparison of Vascular Endothelial Growth Factor-A (VEGF-A) Level in Pleural Fluid of Patients with Malignant and Nonmalignant Pleural Effusion
   Wahyuni Hariyanto et al, 2021, Indian Journal of Surgery CrossRef
6. CHRONIC NEUROGENIC PAIN PROMOTES DEVELOPMENT AND GROWTH OF M1 SARCOMA CHANGING LOCAL LEVELS OF GROWTH FACTORS
   E. M. Frantsiyants et al, 2020, Siberian journal of oncology CrossRef
7. Subcutaneous octreotide therapy for malignant pleural effusion after pleurodesis with talc powder: a placebo-controlled, triple-blind, randomized trial
   Reza Ershadi et al, 2022, Supportive Care in Cancer CrossRef
8. Malignant Pleural Effusion and Its Current Management: A Review
   Kristijan Skok et al, 2019, Medicina CrossRef
9. Exploration in the mechanism of fucosterol for the treatment of non-small cell lung cancer based on network pharmacology and molecular docking
   Xiaoling Li et al, 2021, Scientific Reports CrossRef
10. Machine learning applied to near-infrared spectra for clinical pleural effusion classification
    Zhongjian Chen et al, 2021, Scientific Reports CrossRef
11. Development and validation of the CAIL prognostic score in non‐small cell lung cancer patients with malignant pleural effusion
    Tianyuan Li et al, 2023, The Clinical Respiratory Journal CrossRef
12. Malignant pleural effusion diagnosis and therapy
    Liangliang Yang et al, 2023, Open Life Sciences CrossRef
13. Application Value of Serum TK1 and PCDGF, CYFRA21-1, NSE, and CEA plus Enhanced CT Scan in the Diagnosis of Nonsmall Cell Lung Cancer and Chemotherapy Monitoring
    Xiang He et al, 2022, Journal of Oncology CrossRef
14. Preclinical Characterization of 22-(4′-Pyridinecarbonyl) Jorunnamycin A against Lung Cancer Cell Invasion and Angiogenesis via AKT/mTOR Signaling
    Iksen Iksen et al, 2023, ACS Pharmacology & Translational Science CrossRef
15. Enhancement of Farnesoid X Receptor Inhibits Migration, Adhesion and Angiogenesis through Proteasome Degradation and VEGF Reduction in Bladder Cancers
    Chien-Rui Lai et al, 2022, International Journal of Molecular Sciences CrossRef
16. A Meta-Analysis of the Clinical Efficacy of Hyperthermic Intrathoracic Chemotherapy in the Treatment of Malignant Pleural Effusion Caused by Lung Cancer
    俏苒 李, 2023, Advances in Clinical Medicine CrossRef
17. MicroRNA-181a is elevated by 10-hydroxycamptothecin and represses lung carcinoma progression by downregulating FOXP1
    LI PAN et al, 2022, BIOCELL CrossRef
18. Research progress on anti-ovarian cancer mechanism of miRNA regulating tumor microenvironment
    MingHua Cui et al, 2022, Frontiers in Immunology CrossRef
19. Clinical Value of Pleural Effusion and Serum MMP-3 and CYFRA21-1 Combined with ADA in Differential Diagnosis of Pleural Exudative Effusion
    Zhiyang Xu et al, 2022, Emergency Medicine International CrossRef